GlassScriptPhysician profile
Puja Konda
NPI 1770837189
$9,796.19
in general payments reported to CMS, 2019-2025
39 companies · $2,347 in 2025
The $2,347 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $278 · 2021: $1,626 · 2022: $1,579 · 2023: $1,537 · 2024: $2,068 · 2025: $2,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,653 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,653.46 |
| Education | $298.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,720.93 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $1,031.16 | 2020-2025 | Dupixent, Libtayo |
| Abbvie INC. | $1,022.51 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $915.74 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $733.49 | 2019-2025 | Ilumya |
| E.R. Squibb & Sons, L.L.C. | $598.37 | 2022-2025 | Sotyktu |
| Ucb, INC. | $523.31 | 2021-2025 | Bimzelx |
| Genzyme Corporation | $510.11 | 2021-2025 | |
| Lilly USA, LLC | $421.91 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $313.26 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $258.99 | 2022 | |
| Leo Pharma INC. | $248.98 | 2021-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $238.49 | 2021-2025 | Nemluvio |
| Amgen INC. | $170.19 | 2022-2025 | Otezla, Otezla |
| Organogenesis INC. | $153.50 | 2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puja Konda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.